Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans.
- DOI
- 10.1128/aac.00580-25
- Published
- 2025 Nov 5
- Container
- Antimicrobial agents and chemotherapy
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1128/aac.00580-25,
title = {Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans.},
author = {Gillon J-Y and Simon F and Sidhu S and Louis M and Launay D and Wauthier V and Pelay-Gimeno M and Andel Lv and Loyau S and Rembry S and Weinling E and Tarral A},
year = {2025},
journal = {Antimicrobial agents and chemotherapy},
doi = {10.1128/aac.00580-25},
url = {https://doi.org/10.1128/aac.00580-25}
}RIS
TY - JOUR TI - Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans. AU - Gillon J-Y AU - Simon F AU - Sidhu S AU - Louis M AU - Launay D AU - Wauthier V AU - Pelay-Gimeno M AU - Andel Lv AU - Loyau S AU - Rembry S AU - Weinling E AU - Tarral A PY - 2025 JO - Antimicrobial agents and chemotherapy DO - 10.1128/aac.00580-25 UR - https://doi.org/10.1128/aac.00580-25 ER -
APA
J-Y, G., F, S., S, S., M, L., D, L., V, W., M, P., Lv, A., S, L., S, R., E, W., & A, T. (2025). Mass balance, pharmacokinetics, metabolism, and excretion of radiolabeled acoziborole, a potential novel treatment for human African trypanosomiasis, following single microtracer oral dose to humans.. Antimicrobial agents and chemotherapy. https://doi.org/10.1128/aac.00580-25
Source records
- pubmed · retrieved 2026-09-26T20:15:53.454Z